Rang	Name	Position
1	Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D	Interim CEO & Chairman of the Board
2	Ms. Rhonda L. Hellums	Executive VP, CFO, Secretary & Executive Director
3	Dr. Steven J. Romano M.D.	Executive VP and Chief Research & Development Officer
4	Dr. Marie Wikstrom Lindholm Ph.D.	Chief Scientific Officer
5	Ms. Gem Gokmen Hopkins	Head of IR & Corporate Communications
6	Mr. Jaimin B. Shah	SVP & General Counsel
7	Mr. J.P. Gabriel	Chief Technical Operations Officer
8	Mr. Curtis Rambaran M.D.	Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	TCG Crossover Management, LLC	4,88%	39,50 Mio. USD
2	Siren, L.L.C.	4,68%	37,91 Mio. USD
3	Redmile Group, LLC	3,48%	28,19 Mio. USD
4	Nantahala Capital Management, LLC	3,45%	27,95 Mio. USD
5	Citadel Advisors Llc	2,14%	17,31 Mio. USD
6	Nextech Invest, Ltd.	1,53%	12,40 Mio. USD
7	Millennium Management LLC	1,46%	11,84 Mio. USD
8	Ikarian Capital, LLC	1,39%	11,27 Mio. USD
9	Polygon Management Ltd	1,23%	9,95 Mio. USD
10	Soleus Capital Management, L.P.	1,01%	8,20 Mio. USD
11	5AM Venture Management, LLC	0,77%	6,20 Mio. USD
12	Great Point Partners LLC	0,72%	5,86 Mio. USD
13	SG Americas Securities, LLC	0,46%	3,73 Mio. USD
14	UBS Group AG	0,40%	3,22 Mio. USD
15	BOOTHBAY FUND MANAGEMENT, LLC	0,34%	2,72 Mio. USD
16	BlackRock Inc	0,33%	2,67 Mio. USD
17	BMO Capital Markets Corp.	0,33%	2,64 Mio. USD
18	Bank of Montreal	0,32%	2,63 Mio. USD
19	Propel Bio Management LLC	0,31%	2,50 Mio. USD
20	ADAR1 Capital Management LLC	0,28%	2,24 Mio. USD